Skip to main content
. 2017 Mar 29;8(22):36137–36148. doi: 10.18632/oncotarget.16661

Figure 5. GSC-EXsmiR-21 had better effects than GSC-EXscon and GSC-EXssc on promoting the angiogenic ability of ECs.

Figure 5

(A) representative images and the summarized data showing the tube formation ability of ECs treated by various types of GSC-EXs; bar: 500 μm; (B) summarized data showing the migration ability of ECs in different treatment groups. *p < 0.05, vs. vehicle; +p < 0.05, vs. GSC-EXscon or GSC-EXssc; #p < 0.05, vs. GSC-EXsmiR-21 or GSC-EXsmiR-21+siRNAsc. Data are expressed as mean ± SEM; n = 4/group.